The court directed Sebi to decide on US resident Digvijay ‘Danny’ Gaekwad’s proposed competing offer in accordance with the ...

Gaekwad sought for a special exemption under takeover from the Securities and Exchange Board of India to make an open offer ...

Orbimed Genesis Master Fund L.P. bought 45,000 shares of Mankind Pharma at Rs 2,555.1 per share, while Copthall Mauritius ...

Delhi High Court rejects plea to block investors from voting on Rashmi Saluja's re-appointment, allows Burmans' open offer.

Quarterly Net Loss at Rs. 13.37 crore in December 2024 up 48.15% from Rs. 25.79 crore in December 2023. EBITDA stands ...

Care Health Insurance, India’s second-largest standalone health insurer and Religare’s most valuable asset, has been growing ...

While declining interim relief, the court directed SEBI to swiftly decide on a competing takeover bid, keeping the stage set ...

As the Burman family's open offer for Religare looms, a competing bid from Digvijay Gaekwad adds complexity to the situation.

Danny Gaekwad Developments & Investments, a US-based firm, is challenging Sebi's rejection of its competing open offer for Religare Enterprises Ltd. The firm seeks regulatory exemptions to present a ...

In a setback for Rashmi Saluja, executive chairperson of Religare Enterprises (REL), the Delhi High Court (HC) has denied ...

The Delhi High Court has allowed the Burman family's open offer for acquiring a stake in Religare Enterprises Ltd to proceed, ...

NEW DELHI (Reuters) - India's Religare Enterprises said a U.S. businessman has made a proposal to acquire a 26% stake in it, ...